(Q53434842)

14 May 2018

title

Field cancerization: why late "recurrent" ovarian cancer is not recurrent. (English)

1 reference

14 May 2018

1 reference

R E Buller

1

1 reference

14 May 2018

J S Skilling

2

1 reference

14 May 2018

A K Sood

3

1 reference

14 May 2018

S Plaxe

4

1 reference

14 May 2018

R N Baergen

5

1 reference

14 May 2018

D J Lager

6

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

14 May 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

14 May 2018

volume

178

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

641-649

1 reference

14 May 2018

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: lack of correlation with familial and clinical factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Absence of Significant Germ Line p53 Mutations in Ovarian Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Gene action in the X-chromosome of the mouse (Mus musculus L.)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Multiple malignancy in the upper genital canal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

7 January 2021

Familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

The role of DNA methylation in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970473-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(98)70473-9

1 reference

14 May 2018

1 reference

14 May 2018